Nothing Special   »   [go: up one dir, main page]

WO2009135939A3 - Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma - Google Patents

Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma Download PDF

Info

Publication number
WO2009135939A3
WO2009135939A3 PCT/EP2009/055604 EP2009055604W WO2009135939A3 WO 2009135939 A3 WO2009135939 A3 WO 2009135939A3 EP 2009055604 W EP2009055604 W EP 2009055604W WO 2009135939 A3 WO2009135939 A3 WO 2009135939A3
Authority
WO
WIPO (PCT)
Prior art keywords
medulloblastoma
rhabdomyosarcoma
osteosarcoma
sarcoma
ewing
Prior art date
Application number
PCT/EP2009/055604
Other languages
French (fr)
Other versions
WO2009135939A2 (en
Inventor
Pablo Manuel AVILÉS MARÍN
María del Carmen CUEVAS MARCHANTE
Gilles Vassal
Original Assignee
Pharma Mar, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.
Publication of WO2009135939A2 publication Critical patent/WO2009135939A2/en
Publication of WO2009135939A3 publication Critical patent/WO2009135939A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods for treating cancer by using compound PM02734, in particular, for treating Ewing's sarcoma, osteosarcoma and rhabdomyosarcoma and medulloblastoma are provided.
PCT/EP2009/055604 2008-05-09 2009-05-08 Depsipeptide for use in cancer therapy WO2009135939A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08380145 2008-05-09
EP08380145.6 2008-05-09

Publications (2)

Publication Number Publication Date
WO2009135939A2 WO2009135939A2 (en) 2009-11-12
WO2009135939A3 true WO2009135939A3 (en) 2010-04-29

Family

ID=41265075

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/055604 WO2009135939A2 (en) 2008-05-09 2009-05-08 Depsipeptide for use in cancer therapy

Country Status (1)

Country Link
WO (1) WO2009135939A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036145A2 (en) * 2000-10-31 2002-05-10 Pharma Mar, S.A. Kahalalide f formulation
WO2004035613A2 (en) * 2002-10-18 2004-04-29 Pharma Mar, S.A.U. 4-methylhexanoic kahalaide f compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036145A2 (en) * 2000-10-31 2002-05-10 Pharma Mar, S.A. Kahalalide f formulation
WO2004035613A2 (en) * 2002-10-18 2004-04-29 Pharma Mar, S.A.U. 4-methylhexanoic kahalaide f compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ON BEHALF OF THE ITCC BIOLOGY AND PRECLINICAL EVALUATION COMMITTEE ET AL: "181 POSTER Evaluation of the marine compound PM02734 against a pediatric tumor cell line panel by ITCC preclinical drug evaluation program", EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 6, no. 12, 1 October 2008 (2008-10-01), pages 57 - 58, XP025534243, ISSN: 1359-6349, [retrieved on 20081001] *

Also Published As

Publication number Publication date
WO2009135939A2 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
PL2358697T3 (en) Isoindoline compounds for use in the treatment of cancer.
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
HUE059861T2 (en) N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
WO2007081879A3 (en) Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2008054585A3 (en) Use of pegylated il-10 to treat cancer
WO2009020802A3 (en) Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity
WO2011130164A3 (en) Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
EP2134736A4 (en) Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer
HK1170485A1 (en) 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer 124--3-
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
BRPI0908635A8 (en) compound, pharmaceutical composition and cancer treatment method
WO2007047608A3 (en) Fibrin targeted therapeutics
WO2010032011A8 (en) Anti-fungal therapy
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
MX2008015775A (en) Compounds and compositions for treatment of cancer.
CL2008000629A1 (en) MACROCICLICAL COMPOUNDS DERIVED FROM 6-ARIL-4-MERCAPTO- [1.3.5] TRIAZINA / [1.3] PIRIMIDIN-2-AMINA; PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT OF CANCER.
ZA201000173B (en) Method for treating an at least partially metallised textile, treated textile and the use thereof
WO2010074936A3 (en) Enzastaurin for the treatment of cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
EP2207555A4 (en) Novel compounds for the treatment or alleviation of edema, and methods for their use
EP1865954A4 (en) Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
MX2009009693A (en) Methods of activating irs-1 and akt.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09742157

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09742157

Country of ref document: EP

Kind code of ref document: A2